![Cancer Centers Join to Accelerate Trials, Industry ollaborations, Drug Development](https://cdn.cancerletter.com/media/2024/01/30035841/41-10-OREN.jpg)
![Cancer Centers Join to Accelerate Trials, Industry ollaborations, Drug Development](https://cdn.cancerletter.com/media/2024/01/30035841/41-10-OREN.jpg)
Cover Story
By Matthew Bin Han Ong
Six NCI-designated cancer centers have agreed to pool data from their electronic medical record systems and cancer registries to accelerate discovery of targets and the development of biomarkers.
Conversation with The Cancer Letter
By Matthew Bin Han Ong
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - UChicago Cancer Luminaries Podcast: Todd Golub discusses mentorship, interdisciplinary research